Feb. 5, 2013 New research in animals triggered by a combination of serendipity and counterintuitive thinking could point the way to treating fractures caused by rapid bone loss in people, including patients with metastatic cancers. A series of studies at the University of North Carolina School of Medicine found that steroid drugs, known for inducing bone loss with prolonged use, actually help suppress a molecule that’s key to the rapid bone loss process.
Feb. 5, 2013 A father’s obesity is one factor that may influence his children’s health and potentially raise their risk for diseases like cancer, according to new research from Duke Medicine.
Feb. 1, 2013 Researchers at Moffitt Cancer Center and colleagues at the Mayo Clinic in Rochester, Minn., have developed a novel computer algorithm to easily quantify a major risk factor for breast cancer based on analysis of a screening mammogram
Feb. 1, 2013 According to a study in the January issue of the Journal of the American College of Radiology , the use of volume-modulated arc therapy (VMAT) to deliver intensity-modulated radiation therapy (IMRT) to prostate cancer patients results in an overall reduction in treatment time of approximately 14 percent
Feb. 1, 2013 The shortened daylight of a Maine winter may make for long, dark nights — but it has shone a light on a novel experimental approach to fighting inflammatory breast cancer (IBC), an especially deadly form of breast cancer. The new approach enlists the active form of Vitamin D3, called calcitriol, which is delivered therapeutically by quantum dots
Feb. 1, 2013 A study of more than 12,000 children from emergency departments throughout the country in the Pediatric Emergency Care Applied Research Network (PECARN) has identified seven factors that can help physicians determine the need for a computed tomography (CT) scan following blunt trauma to the abdomen.
Feb. 1, 2013 Biologists at Tufts University School of Arts and Sciences have discovered a bioelectric signal that can identify cells that are likely to develop into tumors
Jan. 31, 2013 A genetically reprogrammed Herpes simplex virus (HSV) can cure metastatic diffusion of human cancer cells in the abdomen of laboratory mice, according to a new study published January 31 in the Open Access journal PLOS Pathogens